tiprankstipranks
Plus Therapeutics (PSTV)
NASDAQ:PSTV
US Market
PSTV
Plus Therapeutics
RESEARCH TOOLSreports
Want to see PSTV full AI Analyst Report?

Plus Therapeutics (PSTV) Stock News & Sentiment

1,716 Followers
Plus Therapeutics Regains Nasdaq Listing Compliance After Reverse Split
Premium
Company Announcements
Plus Therapeutics Regains Nasdaq Listing Compliance After Reverse Split
11d ago
8K
PSTV
PSTV Upcoming Earnings Report: What to Expect?
Premium
Pre-Earnings
PSTV Upcoming Earnings Report: What to Expect?
18d ago
PSTV
Plus Therapeutics Appoints New Chief Development Officer
Premium
Company Announcements
Plus Therapeutics Appoints New Chief Development Officer
23d ago
8K
PSTV
Plus Therapeutics Gains FDA Orphan Status for REYOBIQ
Premium
Company Announcements
Plus Therapeutics Gains FDA Orphan Status for REYOBIQ
24d ago
8K
PSTV
Plus Therapeutics Enacts Reverse Stock Split to Maintain Listing
Premium
Company Announcements
Plus Therapeutics Enacts Reverse Stock Split to Maintain Listing
30d ago
8K
PSTV
Plus Therapeutics Adds Industry Veteran Ronald Andrews to Board
Premium
Company Announcements
Plus Therapeutics Adds Industry Veteran Ronald Andrews to Board
1M ago
8K
PSTV
Plus Therapeutics: Advancing Reyobiq Pipeline and CNSide Commercialization Underpinned by Strong Cash Runway to 2027
Premium
Ratings
Plus Therapeutics: Advancing Reyobiq Pipeline and CNSide Commercialization Underpinned by Strong Cash Runway to 2027
2M ago
PSTV
More PSTV News >

PSTV News on the Web

Plus Therapeutics Bolsters Market Access with Appointment of HEOR Veteran and Targeted Equity Incentives
Market Chameleon
Neutral
PSTV Upcoming Earnings Report: What to Expect?
TipRanks News
Bearish
Plus Therapeutics Appoints New Chief Development Officer
TipRanks News
Neutral
Plus Therapeutics appoints Eric Daniels as chief development officer
TipRanks News
Neutral
Plus Therapeutics Gains FDA Orphan Status for REYOBIQ
TipRanks News
Bearish
Plus Therapeutics granted Orphan Drug Designation for Reyobiq
TipRanks News
Bullish
Analysts Offer Insights on Healthcare Companies: Plus Therapeutics (PSTV) and Terns Pharmaceuticals (TERN)
TipRanks News
Bullish
Plus Therapeutics price target lowered to $12 from $37.50 at Maxim
TipRanks News
Neutral

News Score - Last 7 Days

Neutral
PSTV
Sector Average
Media Buzz
This Week2 articles
Weekly Average3.5 articles
News Sentiment
This Week0%
Sector Average70%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is PSTV’s Media Buzz Sentiment?
2 articles about PSTV were published this week. In an average week, 3.5 articles are published.
    What is PSTV’s weekly average amount of articles?
    In an average week, 3.5 articles about PSTV are published.
      What is PSTV’s News Sentiment?
      Currently, no data Available
      Healthcare Stocks that are Trending in the News
      TVTXTravere Therapeutics
      HVOOpen Orphan Plc
      PBMPsyence Biomedical
      QDELQuidelOrtho
      Showing the stocks with the most bullish news sentiment over the past week